MedTrace Logo

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

NCT03024866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 369

Last updated 2025-02-06

Study results available
· View outcomes & findings →

Summary

This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.

Conditions

  • Nonmelanoma Skin Cancer

Interventions

PROCEDURE

Electronic Brachytherapy

A group receives High-dose-rate electronic brachytherapy (EBT) which provides a non-surgical treatment option and the other group receives Mohs surgery. This matched-pair cohort study compared the outcomes of treatment with EBT to those of Mohs surgery in patients with NMSC.

Sponsors & Collaborators

  • Eminence Clinical Research, Inc.

    collaborator INDUSTRY

  • Xoft, Inc.

    lead INDUSTRY

Principal Investigators

  • Rakesh Patel, MD · Good Samaritan Radiation Oncology

  • Robert Strimling · Strimling Dermatology, Laser, and Vein Institute

Eligibility

Min Age
41 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024866 on ClinicalTrials.gov